EP3057566A1 - Agent cosmétique anti-transpirant contenant des acides polyphosphoriques - Google Patents

Agent cosmétique anti-transpirant contenant des acides polyphosphoriques

Info

Publication number
EP3057566A1
EP3057566A1 EP14796686.5A EP14796686A EP3057566A1 EP 3057566 A1 EP3057566 A1 EP 3057566A1 EP 14796686 A EP14796686 A EP 14796686A EP 3057566 A1 EP3057566 A1 EP 3057566A1
Authority
EP
European Patent Office
Prior art keywords
aluminum
antiperspirant
cosmetic agent
antiperspirant cosmetic
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14796686.5A
Other languages
German (de)
English (en)
Inventor
Bernhard Banowski
Marcus Claas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP3057566A1 publication Critical patent/EP3057566A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds

Definitions

  • the present invention relates to an antiperspirant cosmetic agent which contains at least one antiperspirant aluminum salt and at least one polyphosphoric acid and wherein the addition of the at least one polyphosphoric acid results in an increase in the closure of the sweat gland (s) and / or in a closure formation of the sweat gland (s) ,
  • the present invention relates to the use of a combination of at least one antiperspirant aluminum salt and at least one polyphosphoric acid for reducing and / or preventing underarm perspiration.
  • the present invention relates to a non-therapeutic cosmetic method for preventing and / or reducing transpiration of the body, in which the antiperspirant according to the invention is applied to the skin, in particular to the skin of the armpits.
  • the present invention relates to the use of a polyphosphoric acid to enhance the closure formation of the sweat gland (s) and / or the closure of the sweat gland (s).
  • washing, cleansing and caring for one's own body is a basic human need, and modern industry is constantly trying to meet these needs of man in a variety of ways. Especially important for daily hygiene is the permanent elimination or at least reduction of body odor and underarm wetness.
  • Numerous specific deodorant or antiperspirant personal care products are known in the art which have been developed for use in body regions having a high density of sweat glands, especially in the underarm area. These are formulated in a wide variety of dosage forms, for example as powder, in stick form, as aerosol spray, pump spray, liquid and gel roll on application, cream, gel and as impregnated flexible substrates (towels).
  • Prior art cosmetic antiperspirants contain at least one antiperspirant salt in addition to at least one oil or fatty substance and one perfume component or perfume.
  • the antiperspirant salts used in antiperspirants reduce the sweat secretion of the body through a temporary narrowing or blockage of the excretory ducts of the sweat glands, so that the amount of sweat is about 20 to 60 percent can be reduced. On the other hand, they have an additional deodorizing effect due to their antimicrobial effect.
  • Activated basic aluminum and aluminum zirconium halides as described in the publications EP 0 308 937 A2, EP 0 183 171 A2, US Pat. No. 4,359,456 and EP 0 191 628, are usually used as the antiperspirant salt. It is also possible to use aluminum and aluminum zirconium halides which are stabilized with organic acids as complexing ligands, as described, for example, in US Pat. Nos. 3,542,919, 3,553,316, 3,991,176 and WO 2005/092795 A1 are disclosed.
  • antiperspirant cosmetic agents which have no significant decrease in antiperspirant activity even during long periods of storage and / or when using high levels of protic solvents. Furthermore, the antiperspirants should be inexpensive to produce.
  • R is hydrogen or a linear or branched alkyl group having 1 to 6 carbon atoms
  • R 2 and R 3 are a linear or branched alkyl group having 1 to 6 carbon atoms, or R 2 and R 3 are a cyclic group having 4 to 8 carbon atoms and optionally a heteroatom selected from the group of N, O and S, form, and
  • X + for H + Li + , Na + , K + , NH 4 + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V 4 Zr 4 * or at least one antiperspirant aluminum salt is.
  • hydrogel formation of the antiperspirant aluminum salt and the compound of the formula (PP-I) takes place without wishing to be limited to this theory only at extremely specific pH values. Due to the highly selective formation of the hydrogel at pH values, which are exclusively within the excretory ducts of the sweat glands, an effective blockage of the excretory ducts of the sweat glands is ensured, without the antiperspirant effect of the cosmetic composition according to the invention due to premature undesired hydrogel formation due to the addition of the compound Formula (PP-I) is reduced. Thus, even after prolonged storage periods and / or the presence of high levels of protic solvents, an excellent antiperspirant effect can be ensured.
  • antiperspirant is understood according to the invention to reduce or reduce the perspiration of the sweat glands of the body.
  • cosmetic oil in the sense of the present invention is understood as meaning an oil which is suitable for cosmetic use and which is immiscible with water.Furthermore, the cosmetic oil used according to the invention is neither fragrance nor essential oils.
  • fragments in the context of the present invention means substances having a molecular weight of 74 to 300 g / mol, which contain at least one osmophoric group in the molecule and have an odor and / or taste, ie they are able to Osmophore groups are groups covalently bound to the molecular skeleton in the form of hydroxy groups, formyl groups, oxo groups, alkoxycarbonyl groups, nitrile groups, nitro groups, azide groups, etc.
  • fragments within the meaning of present invention even at 20 ° C and 1013 hPa liquid perfume oils, perfumes, or perfume oil ingredients.
  • the term "waxes" in the context of the present invention means substances which are kneadable at 20 ° C. or solid to brittle, have a coarse to fine-crystalline structure and are translucent to opaque, but not vitreous, in color Substances above 25 ° C without decomposition, slightly liquid above the melting point (slightly viscous), have a strong temperature-dependent consistency and solubility and are polishable under light pressure.
  • volatile cosmetic oil refers to cosmetic oils which at 20 ° C and an ambient pressure of 1 .013 hPa a vapor pressure of 2.66 Pa to 40,000 Pa (0.02 to 300 mm Hg), preferably from 10 to 12,000 Pa (0.1 to 90 mm Hg), more preferably from 13 to 3000 Pa (0.1 to 23 mm Hg), in particular from 15 to 500 Pa (0.1 to 4 mm Hg) have.
  • nonvolatile cosmetic oils in the context of the present invention means cosmetic oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1.103 hPa ,
  • fatty acid as used in the present invention means aliphatic carboxylic acids which have unbranched or branched carbon residues of 4 to 40 carbon atoms also be synthetically produced fatty acids.Furthermore, the fatty acids may be monounsaturated or polyunsaturated.
  • fatty alcohol is to be understood as meaning aliphatic, monohydric, primary alcohols which are unbranched or branched Hydrocarbon radicals having 4 to 40 carbon atoms.
  • the fatty alcohols used in the invention may also be monounsaturated or polyunsaturated.
  • wt .-% refers in the present case, unless otherwise stated, on the total weight of the antiperspirant cosmetic agents according to the invention without any optional propellant.
  • the cosmetic oil which is liquid at 20 ° C and 1013 hPa is selected from the group of
  • volatile cyclic silicone oils especially cyclotrisiloxane, cyclotetrasiloxane, cyclopentasiloxane and cyclohexasiloxane, and linear silicone oils having 2 to 10 siloxane units, especially hexamethyldisiloxane, octamethyltrisiloxane, decamethyltetrasiloxane;
  • volatile non-silicone oils especially liquid paraffin oils and isoparaffin oils such as isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosan;
  • nonvolatile silicone oils especially higher molecular weight linear polyalkylsiloxanes
  • nonvolatile non-silicone oils in particular the esters of linear or branched saturated or unsaturated C 2 to C fatty acids having linear or branched saturated or unsaturated C 2 to C 30 fatty acids which may be hydroxylated, C 8 to C 22 fatty alcohol esters of monovalent or polyvalent C 2 to C fatty acids.
  • C7-hydroxycarboxylic acids the triethyl citrates, the branched saturated or unsaturated C6-3o fatty alcohols, the mono-, di- and triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated Cs-30 fatty acids, the dicarboxylic acid esters of linear or branched C2 -Cio-alkanols, the adducts of ethylene oxide and / or propylene oxide to mono- or polyhydric C3-22 alkanols, which may be esterified, the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, the esters of dimers of unsaturated Ci2-22 Fatty acids with monovalent, linear, branched and cyclic C2 -is-alkanols or C2-6-alkanols, the benzoic acid esters of linear or branched Cs-22-alkanols such as benzoic acid Ci2-is-al
  • the cyclic volatile silicone oils which can be used in the context of the invention have a vapor pressure of from 13 to 15 Pa (0.1 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa. Furthermore, according to the invention as a linear volatile silicone oil and a low molecular weight phenyl Trimethicone be used with a vapor pressure of about 2,000 Pa (15 mm Hg) at 20 ° C and an ambient pressure of 1013 hPa.
  • cyclic volatile silicone oils used in the antiperspirant cosmetic agents according to the invention become.
  • volatile non-silicone oils in the form of Cio-13 isoparaffine mixtures having a vapor pressure of from 10 to 400 Pa (0.08 to 3 mm Hg), preferably from 13 to 100 Pa (0.1 to 0.8 mm Hg) , used at 20 ° C and an ambient pressure of 1 .013 hPa.
  • the volatile C8-Ci6-isoparaffin in a total amount of 1 to 60 wt .-%, preferably from 3 to 45 wt .-%, preferably from 5 to 40 wt .-%, in particular from 8 to 20 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.
  • antiperspirant cosmetic products with a low proportion of volatile oils - that is, with 0.5 to 15 wt .-%, based on the total weight of the antiperspirant cosmetic agent, on volatile oils - or even without volatile oils to formulate.
  • the antiperspirant cosmetic agents comprise a non-volatile silicone oil and / or a non-volatile non-silicone oil.
  • preferred antiperspirant cosmetic agents contain at least one ester of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms, which may be hydroxylated, in a total amount of 1 to 30 wt .-%, preferably from 5 to 26 wt .-%, preferably from 9 to 24 wt .-%, in particular from 12 to 17 wt .-%, based on the total weight of the antiperspirant cosmetic agent.
  • non-volatile silicone oils may be linear polyalkylsiloxanes having a kinematic viscosity of from 5 to 2,000 cSt at 25 ° C., in particular linear polydimethylsiloxanes having a kinematic viscosity at 25 ° C. of from 5 to 2,000 cSt, preferably from 10 to 350 cSt, in particular from 50 to 100 cSt.
  • the non-volatile silicone oils mentioned above are available under the tradenames Dow Corning ® 200 or Xiameter PMX from Dow Corning or Xiameter.
  • nonvolatile silicone oils are phenyltrimethicones having a kinematic viscosity at 25 ° C. of from 10 to 100 cSt, preferably from 15 to 30 cSt, and also cetyldimethicones.
  • Further preferred according to the invention is the use of mixtures of the abovementioned cosmetic oils, in particular nonvolatile and volatile cosmetic oils, since in this way parameters such as skin feel, visibility of the residue and stability of the antiperspirant cosmetic agent according to the invention are adjusted and the agent is thus better suited to the needs of the invention Consumer can be adjusted.
  • the cosmetic oil which is liquid at 20 ° C. and 1 .013 hPa is present in a total amount of from 1 to 95% by weight, preferably from 10 to 85% by weight, preferably from 20 to 75 Wt .-%, more preferably from 35 to 70 wt .-%, in particular from 50 to 60 wt .-%, based on the total weight of the antiperspirant cosmetic agent contained.
  • the antiperspirant compositions according to the invention less than 0.2 wt .-%, preferably less than 0.1 wt .-%, in particular 0 wt .-% of at 20 ° C and 1.
  • the fragrance is selected from the group of
  • esters in particular benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, lactyl acetate, dimethylbenzylcarbinylacetate (DMBCA), phenylethylacetate, benzylacetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate;
  • DMBCA dimethylbenzylcarbinylacetate
  • aldehydes especially linear alkanals of 8 to 18 carbon atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal;
  • ketones especially ionone, alpha-isomethylionone and methyl cedryl ketone
  • alcohols especially anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol;
  • hydrocarbons in particular terpenes such as limonene and pinene; such as
  • mixtures of different fragrances are used, which together have a create an appealing scent.
  • Particularly pleasing antiperspirant cosmetic agents according to the invention are obtained when the perfume in a total amount of 0.00001 to 10 wt .-%, preferably from 0.001 to 9 wt .-%, preferably from 0.01 to 8 wt .-%, further preferably from 0.5 to 7 wt .-%, in particular from 1 to 6 wt .-%, based on the total weight of the antiperspirant cosmetic agent is included.
  • the fragrance in a total amount of 0.00001 to 5 wt .-%, preferably 0.001 to 4 wt .-%, preferably 0.01 to 3 wt .-%, more preferably 0 , 1 to 2 wt .-%, in particular 0.2 to 1, 5 wt .-%, based on the total weight of the blowing agent-containing antiperspirant cosmetic agent is included.
  • the wax is selected from the group of
  • esters of saturated, monohydric Cs -is alcohols with saturated C12is monocarboxylic acids (iii) esters of saturated, monohydric Cs -is alcohols with saturated C12is monocarboxylic acids
  • esters of a saturated, monohydric C 16 -C 6 alkanol and a saturated C 12 -C 36 monocarboxylic acid in particular cetyl behenate, stearyl behenate and C 20 -C 40 -alkyl stearate;
  • glycerol triesters of saturated linear C 12 -C 30 carboxylic acids which may be hydroxylated, in particular hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil, glyceryl tribehenate and glyceryl tri-12-hydroxy stearate;
  • (ix) synthetic waxes in particular montan ester waxes, hydrogenated jojoba waxes and sasol waxes, polyalkylene waxes and polyethylene glycol waxes, C 2o-C4o dialkyl esters of dimer acids, C 30-50 alkyl beeswax and alkyl and alkylaryl esters of dimer fatty acids, paraffin waxes; such as
  • esters of saturated, monohydric Ci2-i8 alcohols with saturated C12 -is monocarboxylic acids are stearyl laurate, cetearyl stearate (eg Crodamol® CSS), cetyl palmitate (eg Cutina® CP) and myristyl myristate (eg Cetiol® MM).
  • cetearyl stearate eg Crodamol® CSS
  • cetyl palmitate eg Cutina® CP
  • myristyl myristate eg Cetiol® MM
  • Farther It is preferable to use a C2o-C4o-alkyl stearate as the wax component. This ester is known under the name Kester ® K82H or Kesterwachs ® K80H and is sold by Koster Keunen Inc..
  • the antiperspirant aluminum salt may be selected from the group of
  • complexes of activated aluminum or aluminum zirconium antiperspirant salts with a polyhydric alcohol containing from 20 to 50% by weight, preferably from 20 to 42% by weight, activated antiperspirant aluminum or aluminum zirconium salt and from 2 to 16 Wt .-% molecularly bound water, the remainder to 100 wt .-% is at least one polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. For example, in documents US 5,643,558 A and US 6,245,325.
  • Preferred activated aluminum-zirconium salts are those of the general formula ZrO (OH) 2-P BYB, wherein Y is Cl, Br, I, NO3 or SO4, b is a rational number from 0.8 to 2 and p is the valence of Y is such that the Al: Zr molar ratio is from 2 to 10 and the metal: (X + Y) ratio is from 0.73 to 2.1, preferably from 0.9 to 1.5.
  • Such activated antiperspirant aluminum zirconium salts are disclosed, for example, in the aforementioned US Pat. No. 6,074,632.
  • a particularly preferred salt is aluminum-zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • Preferred antiperspirant active compounds are disclosed in US 6,663,854 A and US 2004/0009133 A1.
  • the antiperspirant cosmetic agent comprises at least one compound of the formula (PP-la)
  • the antiperspirant cosmetic agent a weight ratio of the antiperspirant aluminum salt to the compound of formula (PP-I) of 1: 1, 5 to 1: 40, preferably from 1: 2 to 1: 35, more preferably from 1: 2.5 to 1: 30 , even more preferably from 1: 3 to 1:25, in particular from 1: 3.5 to 1:20.
  • the above-mentioned weight ratio refers to the total amount of all antiperspirant aluminum salts and the total amount of all compounds of formula (PP-I) in the antiperspirant cosmetic agent.
  • the weight ratio of the antiperspirant aluminum salt to the compound of formula (PP-I) is 1, 5: 1.
  • the use of a weight ratio of the antiperspirant aluminum salt to the compound of formula (PP-I) of 10: 1 to antiperspirant cosmetic agents according to the invention which have an excellent antiperspirant effect.
  • protic solvents in particular in high concentrations or amounts, can be used without the antiperspirant effect of the antiperspirant cosmetic agents according to the invention being adversely affected, so that an extremely flexible formulation of the compositions according to the invention is possible.
  • the antiperspirant cosmetic agent preferably contains free water in a total amount of less than 10% by weight, preferably less than 8% by weight, preferably less than 5% by weight, more preferably less than 3% by weight. even more preferably less than 1% by weight, in particular 0% by weight, based on the total weight of the antiperspirant cosmetic agent.
  • free water is thus understood to mean water which is different from water of crystallization, water of hydration or similar molecularly bound water of the constituents used, in particular the antiperspirant aluminum salts.
  • the antiperspirant cosmetic agent is present as an oil-in-water emulsion.
  • the agent according to the invention is preferably sprayed as a propellant-free pump spray or Ouetschspray or applied as a roll-on.
  • the antiperspirant cosmetic agent is present as an aqueous, aqueous-alcoholic or aqueous-glycolic solution.
  • an antiperspirant aluminum salt with at least one compound of the formula (PP-I) even protic solvents, such as aqueous solutions, can be used to formulate the antiperspirant cosmetic agents according to the invention without a significant reduction in the antiperspirant effect occurring.
  • the addition of the at least one compound of the formula (PP-I) ensures effective closure formation of the excretory ducts of the sweat glands even when using protic solvents and thus an excellent antiperspirant effect.
  • the antiperspirant cosmetic agent contains ethanol in a total amount of 1 to 50 wt .-%, preferably from 5 to 40 wt .-%, preferably from 7 to 35 wt .-%, in particular from 10 to 30 Wt .-%, based on the total weight of the antiperspirant cosmetic agent.
  • the antiperspirant cosmetic agent is formulated as a spray application.
  • the spray application is carried out with a spray device which contains a filling of the liquid, viscous-flowable, suspension-shaped or powdered antiperspirant cosmetic agent according to the invention in a container.
  • the filling may be under the pressure of a propellant (compressed gas cans, compressed gas packages, aerosol dispensers), or it may be a mechanically operated pump sprayer without propellant (pump sprays / squeeze bottle).
  • the containers have a removal device, preferably in the form of valves, which allow the removal of the contents as a mist, smoke, foam, powder, paste or liquid jet.
  • the antiperspirant cosmetic is preferably formulated as a stick, soft solid, cream, roll-on, dibenzylidenalditol-based gel, loose or compact powder.
  • the formulation of the antiperspirant cosmetic agents according to the invention in a particular dosage form such as, for example, an antiperspirant roll-on, an antiperspirant stick or an antiperspirant gel, preferably conforms to the requirements of the intended use.
  • the antiperspirant cosmetic agents according to the invention can therefore be in solid, semisolid, liquid, disperse, emulsified, suspended, gelatinous, multiphase or powdered form.
  • the term liquid also includes any types of solid dispersions in liquids.
  • wipes can be made of a fibrous or cellular flexible material which has sufficient mechanical stability and softness for application to the skin.
  • wipes include wipes of woven and nonwoven synthetic and natural fibers, felt, paper or foam, such as hydrophilic polyurethane foam.
  • Deodorizing or antiperspirant substrates which are preferred according to the invention can be obtained by impregnation or impregnation or else by melting a perspiration-inhibiting cosmetic agent according to the invention onto a substrate.
  • Emulsifiers and surfactants which are preferably suitable according to the invention are selected from anionic, cationic, nonionic, amphoteric, in particular ampholytic and zwitterionic emulsifiers and surfactants.
  • Surfactants are amphiphilic (bifunctional) compounds which consist of at least one hydrophobic and at least one hydrophilic moiety.
  • the hydrophobic moiety is preferably a hydrocarbon chain of 8 to 28 carbon atoms, which may be saturated or unsaturated, linear or branched. Most preferably, this C8-C28 alkyl chain is linear.
  • Cationic surfactants are understood as meaning surfactants with exclusively cationic charges; they contain z.
  • Preferred esterquats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • amphoteric surfactants are subdivided into ampholytic surfactants and zwitterionic surfactants.
  • Ampholytic surfactants are to be understood as meaning those surface-active compounds which have both acidic (for example -COOH or -SOßH groups) and basic hydrophilic groups (for example amino groups) and thus behave acidic or basic depending on the condition.
  • Zwitterionic surfactants are understood by the person skilled in the art to be surfactants which carry both a negative and a positive charge in the same molecule.
  • Examples of preferred zwitterionic surfactants are the betaines, the N-alkyl-N, N-dimethylammonium glycinates, the N-acyl-aminopropyl-N, N-dimethylammoniumglycinate and the 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazoline with each 8 to 24 carbon atoms in the alkyl group.
  • HLB (100-L): 5 where L is the weight fraction of the lipophilic groups, that is the fatty alkyl or fatty acyl groups, in the ethylene oxide adducts, expressed in weight percent.
  • L is the weight fraction of the lipophilic groups, that is the fatty alkyl or fatty acyl groups, in the ethylene oxide adducts, expressed in weight percent.
  • a water-in-oil emulsifier having an HLB value of greater than 1.0 and less than or equal to 7.0 is used.
  • Nonionic oil-in-water emulsifiers suitable for the purposes of the present invention and suitable nonionic water-in-oil emulsifiers are described, for example, in German Offenlegungsschrift DE 10 2006 004 957 A1.
  • Particularly preferred thickening agents are selected from cellulose ethers, especially from hydroxyalkylcelluloses, in particular from hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxyethylcellulose, carboxymethylcellulose, cetylhydroxyethylcellulose, hydroxybutylmethylcellulose and methylhydroxyethylcellulose, and mixtures thereof. Hydroxyethyl cellulose is preferably used as thickener.
  • the antiperspirant cosmetic agents may be advantageous to the antiperspirant cosmetic agents according to the invention at least one chelating agent which is selected from ethylenediaminetetraacetic acid (EDTA) and its salts and from nitrilotriacetic acid (NTA) and mixtures of these substances, in a total amount of 0.01 to 0.5 wt .-%, preferably from 0, 02 to 0.3 wt .-%, in particular from 0.05 to 0.1 wt .-%, based on the total weight of the antiperspirant agent according to the invention, to add.
  • EDTA ethylenediaminetetraacetic acid
  • NDA nitrilotriacetic acid
  • chelating agents which are selected from the group of ⁇ -alaninediacetic acid, cyclodextrin, diethylenetriaminepentamethylenephosphonic acid, sodium, potassium, calcium disodium, ammonium and triethanolamine salts of ethylenediaminetetraacetic acid (EDTA), etidronic acid, can also be used in the context of the present invention.
  • EDTA ethylenediaminetetraacetic acid
  • the antiperspirant effect of the antiperspirant cosmetic agents according to the invention can be further increased if at least one deodorant active ingredient in a total amount of 0.0001 to 40 wt .-%, preferably from 0.2 to 20 wt .-%, preferably from 1 to 15 wt .-%, in particular from 1, 5 to 5 wt .-%, based on the total weight of the antiperspirant cosmetic agent according to the invention, is included. If ethanol is used in the compositions according to the invention, this does not apply in the context of the present invention as a deodorant active ingredient, but as a constituent of the carrier.
  • Preferred antiperspirant cosmetic agents according to the invention furthermore comprise at least one water-soluble polyvalent C 2-9 -alkanol having 2 to 6 hydroxyl groups and / or min. at least one water-soluble polyethylene glycol having 3 to 50 ethylene oxide units and mixtures thereof. This does not include the abovementioned deodorant active ingredients in the form of 1, 2-alkanediols.
  • Preferred alkanols are selected from 1, 2-propylene glycol, 2-methyl-1, 3-propanediol, glycerol, 1, 2-butylene glycol, 1, 3-butylene glycol, 1, 4-butylene glycol, pentylene glycols such as 1, 2-pentanediol and 1, 5-pentanediol, hexanediols such as 1, 2-hexanediol and 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol , Erythritol, sorbitol, cis-1,4-dimethylolcyclohexane, trans-1,4-dimethylolcyclohexane, any mixtures of isomers
  • Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.
  • Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol, menthylpyrrolidonecarboxylic acid and 5-methyl-2- (1-methylethyl) cyclohexyl-N-ethyloxamate, as well as mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
  • the antiperspirant cosmetic agents according to the invention contain a propellant.
  • propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1, 1 - difluoroethane, tetrafluoropropenes, both individually and in their mixtures.
  • the total amount of the blowing agent is 20 to 95 wt.%, Preferably 30 to 85 wt.%, In particular 40 to 75 wt .-%, each based on the total weight of the antiperspirant, consisting of the inventive antiperspirant cosmetic agents and the propellant.
  • the total amount of blowing agent 1 to 95 wt .-%, preferably 2 to 85 wt .-%, in particular 3 to 75 wt .-%, .-%, each based on the total weight of Antiperspirant, consisting of the antiperspirant cosmetic agent of the invention and the propellant is.
  • lipophilic thickeners can furthermore be used according to the invention.
  • the at least one antiperspirant aluminum salt is preferably suspended undissolved in at least one cosmetic oil which is liquid at 20 ° C. and 1 .013 hPa.
  • at least one lipophilic thickener may be added to this suspension as a suspending aid.
  • Lipophilic thickeners preferred according to the invention are selected from hydrophobized clay minerals and fumed silicic acids.
  • the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as an oil-in-water emulsion and - based on the total weight of the antiperspirant cosmetic agent according to the invention - at least one antiperspirant aluminum salt in a total amount of 2 to 75 wt %, preferably 3 to 70% by weight, preferably 4 to 65% by weight, more preferably 5 to 55% by weight, even more preferably 8 to 40% by weight, in particular 10 to 30% by weight.
  • % at least one compound of the formula (PP-I) in a total amount of 0.05 to 20 wt .-%, preferably 0.1 to 15 wt .-%, preferably 0.3 to 10 wt .-%, more preferably 0 , 5 to 7 wt .-%, still more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%, 15 to 90 wt .-%, preferably 25 to 55 wt .-%, preferably 30 to 50% by weight, in particular 35 to 45% by weight of water,
  • a further preferred embodiment of the present invention comprises antiperspirant cosmetic agents according to the invention, which are characterized in that they comprise, based on the total weight of the antiperspirant cosmetic agent according to the invention, at least one antiperspirant aluminum salt in a total amount of 2 to 75% by weight, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, even more preferably 8 to 40 wt .-%, in particular 10 to 30 wt .-%, at least one compound of the formula (PP-I) in a total amount of 0.05 to 20 wt .-%, preferably 0.1 to 15 wt .-%, preferably 0.3 to 10 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%, 15 to 90 wt .-%, preferably 25 to
  • a further preferred embodiment of the present invention comprises antiperspirant cosmetic agents according to the invention, which are characterized in that they comprise, based on the total weight of the antiperspirant cosmetic agent according to the invention, at least one antiperspirant aluminum salt in a total amount of 2 to 75% by weight, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, even more preferably 8 to 40 wt .-%, in particular 10 to 30 wt .-%, at least one compound of the formula (PP-I) in a total amount of 0.05 to 20 wt .-%, preferably 0.1 to 15 wt .-%, preferably 0.3 to 10 wt .-%, more preferably 0.5 to 7 wt .-%, more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%, 15 to 90 wt .-%, preferably 25 to
  • the antiperspirant cosmetic agents according to the invention have a dynamic viscosity in the range from 10 to 5000 mPas, preferably from 100 to 1000 mPas, preferably from 200 to 800 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s, without Helipath at 20 ° C ambient temperature and 20 ° C sample temperature.
  • a further preferred embodiment of the present invention comprises antiperspirant cosmetic agents according to the invention, which are characterized in that they comprise, based on the total weight of the antiperspirant cosmetic agent according to the invention, at least one antiperspirant aluminum salt in a total amount of 2 to 75% by weight, preferably 3 to 70 wt .-%, preferably 4 to 65 wt .-%, more preferably 5 to 55 wt .-%, even more preferably 8 to 40 wt .-%, in particular 10 to 30 wt .-%, at least one compound of the formula (PP-I) in a total amount of 0.05 to 8 wt .-%, preferably 0.1 to 7 wt .-%, preferably 0.3 to 5 wt .-%, more preferably 0.5 to 3 wt .-%, more preferably 0.8 to 2.5 wt .-%, in particular 1 to 2 wt .-%, 15 to 90 wt .-%, preferably 25 to
  • the antiperspirant cosmetic agents according to the invention have a dynamic viscosity in the range of 1 .000 to 800,000 mPas, preferably from 2,000 to 700,000 mPas, preferably from 3,000 to 500,000 mPas, measured with a Brookfield viscometer, spindle RV 4, 20 s ⁇ without Helipath, at 20 ° C ambient temperature and 20 ° C sample temperature exhibit.
  • the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as a water-in-oil emulsion and - based on the total weight of the antiperspirant cosmetic agent according to the invention - at least one antiperspirant aluminum salt in a total amount of 2 to 75 wt %, preferably 3 to 70% by weight, preferably 4 to 65% by weight, more preferably 5 to 55% by weight, even more preferably 8 to 40% by weight, in particular 10 to 30% by weight.
  • % at least one compound of formula (PP-I) in a total amount of 0.05 to 20 wt .-%, preferably 0.1 to 15 wt .-%, preferably 0.3 to 10 wt .-%, further preferably 0.5 to 7 wt .-%, still more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%, 15 to 75 wt .-%, preferably 25 to 60 wt .-%, preferably from 30 to 55% by weight, in particular from 35 to 50% by weight, of water
  • the antiperspirant cosmetic agents according to the invention are characterized in that they are formulated as an oil-in-water emulsion and - based on the total weight of the antiperspirant cosmetic agent according to the invention - at least one antiperspirant aluminum salt in a total amount of 2 to 75 wt %, preferably 3 to 70% by weight, preferably 4 to 65% by weight, more preferably 5 to 55% by weight, even more preferably 8 to 40% by weight, in particular 10 to 30% by weight.
  • % at least one compound of formula (PP-I) in a total amount of 0.05 to 20 wt .-%, preferably 0.1 to 15 wt .-%, preferably 0.3 to 10 wt .-%, further preferably 0.5 to 7 wt .-%, still more preferably 0.8 to 5 wt .-%, in particular 1 to 3 wt .-%, 15 to 90 wt .-%, preferably 25 to 80 wt .-%, preferably 30 to 75 wt .-%, in particular 40 to 60 wt .-% water, and
  • compositions according to the invention can therefore, as kit-of-parts, containing, separated from one another, a) at least one first container containing a cosmetic agent comprising at least one antiperspirant aluminum-containing compound, and
  • aluminum-containing compounds is understood to mean antiperspirant aluminum salts and aluminum-zirconium salts.
  • a second object of the present invention is the use of a combination of at least one selected from the group of cosmetic oils which are liquid at 20 ° C and 1 .013 hPa, fragrances and waxes, at least one antiperspirant aluminum salt in a total amount of from 0.1 to 80% by weight, based on the total weight of the combination, of at least one compound of the formula (PP-I)
  • R is hydrogen or a linear or branched alkyl group having 1 to 6 carbon atoms
  • R 2 and R 3 are a linear or branched alkyl group having 1 to 6 carbon atoms, or R 2 and R 3 are a cyclic group having 4 to 8 carbon atoms and optionally a heteroatom selected from the group of N, O and S, form, and
  • X + for KT Li + , Na + , K + , NH 4 + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V 4 Zr 4 * or at least one antiperspirant aluminum salt,
  • the term "combination" within the meaning of the present invention also encompasses a mixture of the at least one substance and the antiperspirant aluminum salt with the at least one compound of the formula (PP-I) antiperspirant cosmetic means said.
  • a cosmetic agent containing an antiperspirant aluminum salt and then an aluminum salt-free cosmetic agent containing at least one compound of the formula (PP-I) is applied.
  • the aluminum salt-free cosmetic agent comprising at least one compound of the formula (PP-I)
  • a cosmetic agent containing an antiperspirant aluminum salt is applied.
  • the time between application of the two remedies is from 10 seconds to 24 hours.
  • a fourth subject of the present invention is the use of at least one compound of the formula (PP-I)
  • R is hydrogen or a linear or branched alkyl group having 1 to 6 carbon atoms
  • R 2 and R 3 are a linear or branched alkyl group having 1 to 6 carbon atoms, or R 2 and R 3 are a cyclic group having 4 to 8 carbon atoms and optionally a heteroatom selected from the group of N, O and S, form, and
  • X + for KT Li + , Na + , K + , NH 4 + , V 2 Mg 2+ , V 2 Ca 2+ , V 2 Mn 2+ , V 2 Zn 2+ , V 3 Al 3+ , V 4 Zr 4 * or at least one antiperspirant aluminum salt,
  • Closure formation of the sweat gland (s) is understood to mean the formation of a hydrogel and / or precipitate from the at least one antiperspirant aluminum salt and the at least one compound of the formula (PP-I) in the excretory duct of the sweat gland or the excretory ducts of the sweat glands.
  • the formation of a seal is also understood to mean the support of the formation of a precipitate of the antiperspirant aluminum salt by the addition of the compound of the formula (PP-I). This occlusion avoids or reduces secretion of sweat from the duct.
  • the statements made on the cosmetic antiperspirant compositions according to the invention apply mutatis mutandis.
  • a beaker 100 ml of demineralized water are introduced and then added 35 ml of a dilution of the solution indicated in Table 1.
  • the solutions from Table 1 are diluted in a beaker to an aluminum salt content of 1, 25 wt .-%.
  • the pH of the solution in the beaker is adjusted to pH 6.5 to 6.6 by addition of a 2% sodium bicarbonate solution with stirring.
  • the turbidity of the solution is measured with a Methrom Optrode 6.11 15,000 at a wavelength of 574 nm (green-yellow) in mV (resolution 0.1 mV). The higher the turbidity of the solution, the lower the measured value obtained in mV. Each measurement is carried out twice and from this the mean value is formed.
  • the turbidity is a measure of the potential of the mixture for hydrogel formation.
  • the compound of the formula (PP-I) used in the following examples is preferably the acetylcycloheptanediphosphoric acid or its salts (formula PP-1a) and mixtures thereof:
  • Antiperspirant cosmetic agents according to the invention (amounts in% by weight) 1 2 3 4 5 6
  • Cyclomethicone (at least 95% by weight cyclopentad ad ad ad siloxane) 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
  • Antiperspirant cosmetic agents according to the invention in the form of an oil-in-water emulsion (amounts in% by weight)
  • Antiperspirant cosmetic agents according to the invention in the form of microemulsions (in% by weight)
  • Antiperspirant cosmetic compositions according to the invention in the form of roll-ons (amounts in% by weight)
  • a single-layer substrate of 100% viscose having a weight per unit area of 50 g / m 2 was applied to 75 g each of the exemplary emulsions 13 or 14 per square meter or 75 g each of the exemplary compositions 9 and 10, respectively. cut into cloths of suitable size and packed in sachets.
  • Antiperspirant cosmetic agents according to the invention (amounts in% by weight, based on the total weight of the blowing agent-free composition)
  • Example compositions 26-29 were charged to an aluminum spray can optionally coated with epoxy-phenolic paint in a weight ratio of propellant (butane / propane / isobutane mixture) to suspension of 80:20, 85:15, 60:40 and 90:10, respectively.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic agents according to the invention (amounts in% by weight, based on the total weight of the blowing agent-free composition)
  • Example compositions 30-32 were packed into an optionally epoxy-phenolic varnish-sprayed aluminum spray can in a weight ratio of propellant (butane / propane / isobutane mixture) to suspension of 80:20, 85:15, 60:40 and 90:10, respectively.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic agents according to the invention in the form of O / W emulsions (amounts in parts by weight)
  • Antiperspirant cosmetic agents according to the invention (amounts in% by weight, based on the total weight of the blowing agent-free composition)
  • Example compositions 36-39 were packed into an optionally epoxy-phenolic lacquer sprayed aluminum spray can in a weight ratio of propellant (butane / propane / isobutane mixture) to suspension of 80:20, 85:15, 60:40 and 90:10, respectively.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic compositions according to the invention in the form of W / O emulsions (amounts in% by weight)
  • Plantar ® 2000 DECYL GLUCOSIDE about 50% AS BASF

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne un agent cosmétique anti-transpirant, contenant : a) au moins une substance choisie dans le groupe constitué par des huiles cosmétiques liquides à 20 °C et 1013 hPa, des parfums et des cires; b) au moins un sel d'aluminium anti-transpirant en une quantité totale de 0,1 à 80 % en poids, rapportée au poids total de l'agent cosmétique anti-transpirant; et c) au moins un composé de formule (PP‑I), où R1 représente l'hydrogène ou un groupe alkyle linéaire ou ramifié contenant 1 à 6 atomes de carbone, R2 et R3 représentent chacun indépendamment de l'autre un groupe alkyle linéaire ou ramifié contenant 1 à 6 atomes de carbone, ou R2 et R3 forment un groupe cyclique contenant 4 à 8 atomes de carbone et facultativement un hétéroatome choisi dans le groupe des éléments N, O et S, et X+ représente H+, Li+, Na+, K+, NH4+, 1/2 Mg2+, 1/2 Ca2+, 1/2 Mn2+, 1/2 Zn2+, 1/3 Al3+, 1/4 Zr4+ ou au moins un sel d'aluminium anti-transpirant. L'ajout du ou des composés de formule (PP‑I) entraîne un blocage efficace des canaux excréteurs des glandes sudoripares.
EP14796686.5A 2013-10-15 2014-09-26 Agent cosmétique anti-transpirant contenant des acides polyphosphoriques Withdrawn EP3057566A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE201310220770 DE102013220770A1 (de) 2013-10-15 2013-10-15 Schweißhemmende kosmetische Mittel mit Polyphosphorsäuren
PCT/DE2014/200514 WO2015055197A1 (fr) 2013-10-15 2014-09-26 Agent cosmétique anti-transpirant contenant des acides polyphosphoriques

Publications (1)

Publication Number Publication Date
EP3057566A1 true EP3057566A1 (fr) 2016-08-24

Family

ID=51897033

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14796686.5A Withdrawn EP3057566A1 (fr) 2013-10-15 2014-09-26 Agent cosmétique anti-transpirant contenant des acides polyphosphoriques

Country Status (4)

Country Link
US (1) US9724286B2 (fr)
EP (1) EP3057566A1 (fr)
DE (1) DE102013220770A1 (fr)
WO (1) WO2015055197A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015213345A1 (de) * 2015-07-16 2017-01-19 Henkel Ag & Co. Kgaa Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von Phosphatverbindungen und schweißhemmenden Aluminium- und/oder Aluminium-Zirkoniumsalzen
BR112020011181B1 (pt) 2017-12-14 2023-01-31 Colgate-Palmolive Company Composição antitranspirante/desodorante e método para aplicação da mesma
FR3119321A1 (fr) * 2021-02-04 2022-08-05 L'oreal Poudre cosmétique de prévention et/ou traitement de la transpiration et composition associée

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3542919A (en) 1956-06-04 1970-11-24 Wickhen Products Inc Astringent alkali metal aluminum complexes of hydroxy acids
GB1054265A (fr) 1962-11-07 1900-01-01
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US3991176A (en) 1973-11-23 1976-11-09 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with hydroxy carboxylic compounds
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
IL77011A (en) 1984-11-21 1988-12-30 Armour Pharma Aluminum chlorhydrates,antiperspirant compositions containing the same and methods for the preparation thereof
GB8503672D0 (en) 1985-02-13 1985-03-13 Unilever Plc Basic aluminium halides
US4818512A (en) 1987-09-23 1989-04-04 Bristol-Myers Company Activated aluminum chlorhydroxide
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US5972321A (en) * 1998-06-30 1999-10-26 Akpharma Inc. Acid neutralization of skin
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
JP2004067665A (ja) * 2002-06-12 2004-03-04 Kao Corp 外用剤組成物
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US6835373B2 (en) 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
DE102004015025A1 (de) 2004-03-26 2005-10-13 Clariant Gmbh Basische Aluminiumhalogenid-Komplexe
DE102006004957A1 (de) 2006-02-01 2007-08-02 Henkel Kgaa Rückstandsarmer Deodorant- oder Antitranspirant-Stift auf Basis einer Öl-in-Wasser-Dispersion/Emulsion
DE102007028508A1 (de) * 2007-06-18 2008-04-03 Henkel Kgaa Stabilisierung von Deodorantien und Antitranspirantien

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO2015055197A1 *

Also Published As

Publication number Publication date
WO2015055197A1 (fr) 2015-04-23
US20160206541A1 (en) 2016-07-21
DE102013220770A1 (de) 2015-04-16
US9724286B2 (en) 2017-08-08

Similar Documents

Publication Publication Date Title
WO2015085998A1 (fr) Produits cosmétiques antitranspirants sans composés contenant de l'aluminium
EP2651521A2 (fr) Compositions anti-transpirantes aqueuses à masquage amélioré des sels résiduels
DE102015225958A1 (de) Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen
DE102017201025A1 (de) "Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen"
EP3057570B1 (fr) Utilisation des polysaccharides dans des antiperspirants pour la protection de textiles
WO2015085999A1 (fr) Produit cosmétique anti-transpirant sans composés contenant de l'aluminium
EP3057665A1 (fr) Agent cosmétique anti-transpiration contenant des lactates
DE102015225876A1 (de) "Deodorantien, enthaltend spezielle kationische Morpholinoverbindungen in Kombination mit bestimmten Deowirkstoffen"
DE102009027050A1 (de) Antitranspirant-Sprays
WO2015055197A1 (fr) Agent cosmétique anti-transpirant contenant des acides polyphosphoriques
WO2015055198A1 (fr) Agent cosmétique anti-transpiration contenant des acides sulfoniques aromatiques
WO2015055195A1 (fr) Produit cosmétique anti-transpirant contenant des acides amidosulfoniques
DE102015225892A1 (de) Deodorantien, enthaltend spezielle cyclische Alkohole in Kombination mit bestimmten Deowirkstoffen
DE102016221154A1 (de) Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen
EP3057568B1 (fr) Utilisation de l'acide méthanesulfonique et de ses sels pour l'activation et/ou stabilisation des sels d'aluminium anti-transpirants
EP3057565A2 (fr) Agent cosmétique anti-transpirant comprenant des acides polycarboxyliques
EP3057567A2 (fr) Produits cosmétiques anti-transpirants aux alpha-hydroxyacides
EP3206657B1 (fr) Anti-perspirant avec aluminumsesquichlorohydrat et acide citrique triéthylique
DE102014205199A1 (de) Schweißhemmende kosmetische Mittel enthaltend wasserlösliche Polysaccharide
WO2015085996A1 (fr) Produits cosmétiques antitranspirants contenant du lysozyme et/ou de l'albumine de sérum bovin et/ou de la protéine de yaourt
DE102015225971A1 (de) Verfahren zur Reduzierung des durch die Transpiration ausgelösten Körpergeruchs unter Verwendung von speziellen Proteinhydrolysaten
DE102013220782A1 (de) Schweißhemmende kosmetische Mittel mit Phenylcarbonsäuren
WO2013092185A2 (fr) Anti-transpirants ménageant les textiles
DE102015223846A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen Alkoholen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20180111

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/55 20060101AFI20190624BHEP

Ipc: A61K 8/26 20060101ALI20190624BHEP

Ipc: A61K 8/31 20060101ALI20190624BHEP

Ipc: A61K 8/37 20060101ALI20190624BHEP

Ipc: A61K 8/92 20060101ALI20190624BHEP

Ipc: A61K 8/891 20060101ALI20190624BHEP

Ipc: A61Q 15/00 20060101ALI20190624BHEP

Ipc: A61K 8/34 20060101ALI20190624BHEP

INTG Intention to grant announced

Effective date: 20190718

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191129